Levofloxacina Basi

Levofloxacin, the active ingredient in Levofloxacina Basi, is a fluoroquinolone antibiotic presented as an intravenous solution for IV use. It treats a range of serious bacterial infections in adults and children when oral therapy is unsuitable, including pneumonia, complicated urinary tract infections, and intra‑abdominal infections.

GNH USA supplies Levofloxacina Basi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacina Basi is a fluoroquinolone antibacterial used for infections that require intravenous therapy.

- Community‑acquired pneumonia: eradicates typical and atypical respiratory pathogens, improving lung function. - Complicated urinary tract infection: eliminates Gram‑negative organisms, resolving bacteriuria and pyelonephritis. - Intra‑abdominal infection: provides broad coverage against aerobic and anaerobic bacteria in peritonitis. - Skin and soft‑tissue infection: treats severe cellulitis and wound infections caused by susceptible strains. - Bacterial prostatitis: penetrates prostatic tissue to clear chronic infection.

Levofloxacina Basi may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, often self‑limiting. - Headache: transient cranial discomfort. - Dizziness: occasional vertigo or light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient hepatic enzyme rise.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles, requiring immediate discontinuation. - QT interval prolongation: may precipitate cardiac arrhythmias. - Severe hypersensitivity: anaphylaxis or Stevens‑Johnson syndrome. - Clostridioides difficile colitis: severe diarrhea with pseudomembranous colitis. - Central nervous system effects: seizures or psychosis. - Hepatotoxicity: marked liver injury with jaundice.

Levofloxacina Basi requires careful patient assessment before use.

- Renal impairment: adjust dose based on creatinine clearance. - QT prolongation risk: obtain baseline ECG and monitor cardiac rhythm. - Pregnancy and lactation: use only if benefits outweigh potential fetal or infant risk. - Tendon disorders: avoid in patients with a history of tendon disease or who are on corticosteroids. - Hypersensitivity: discontinue immediately if allergic reaction occurs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Levofloxacina Basi can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antacids containing aluminum or magnesium: markedly reduce levofloxacin absorption. - Warfarin: potentiates anticoagulant effect, increasing bleeding risk. - Theophylline: inhibits metabolism, raising serum theophylline levels. - Ciprofloxacin: additive QT‑prolongation, heightening arrhythmia risk.

Moderate Interactions (Monitor Closely): - Corticosteroids: increased chance of tendon rupture. - Diabetes medications: may affect glycemic control. - Cyclosporine: elevated cyclosporine concentrations. - NSAIDs: heightened risk of central nervous system stimulation.